>

MEETINGS / EVENTS

RSS

November 08 - 09 2014, 12:00 AM - 12:00 AM

ASA Quality Meeting 2014

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

>

FDA MEDWATCH ALERTS

October 20, 2014

Lidocaine HCI Injection, USP 10 MG Per ML, 30 ML Single-Dose, Preservative-Free, by Hospira: Recall - Particulate Matter

Summary:

FDA Medwatch Alert 10-20-14

October 16, 2014

FDA MedWatch - LifeCare Flexible Intravenous Solutions by Hospira, Inc.: Recall - Potential for Leakage

Summary:

FDA MedWatch LifeCare Flexible Intravenous Solutions by Hospira Inc

October 13, 2014

FDA MedWatch - CareFusion EnVe and ReVel Ventilators: Class 1 Recall - Power Connection Failure

Summary:

FDA MedWatch CareFusion EnVe and ReVel Ventilators

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

ASA Continues to Urge CMS to Make Changes to Meaningful Use Incentive Program

Tuesday, May 08, 2012

In a formal comment letter, ASA urged the Centers for Medicare & Medicaid Services (CMS) to make changes to the Meaningful Use Stage 2 proposed rule. As written, the proposed rule still does not adequately address the modifications needed for anesthesiologists to participate in the incentive program.  Currently, a majority of anesthesiologists are deemed eligible for the incentive, but are unable to successfully satisfy the meaningful use criteria due to the nature of anesthesiology practices and the ways in which anesthesiologists use Electronic Health Record (EHR) systems.

ASA expressed concern that despite Congressional intent anesthesiologists are not deemed a hospital based eligible professional as defined by the regulations. ASA has continued to recommended criteria that would allow anesthesiologists to participate, or alternatively, that anesthesiologists be able to apply for a hardship exemption.

ASA has repeatedly advocated these concerns to CMS and the Office of the National Coordinator (ONC) on several occasions over the past several years and will continue to actively seek the necessary modifications for anesthesiologist participation.

Review ASA’s communication to the proposed rule on Meaningful Use Stage 2.
Review ASA's Anaylsis and Recommendations for Meaningful Use Requirements. 
Review background on EHRs.

« Back to Washington Alerts